Levofloxacin prophylaxis: SoC for newly diagnosed myeloma?
07 Nov 2019
bởiAudrey Abella
The addition of the fluoroquinolone levofloxacin to myeloma therapy during the first 12 weeks led to a significant reduction in febrile episodes and deaths compared with placebo, suggesting that levofloxacin prophylaxis could be a standard of care in the first 3 months following myeloma diagnosis to prevent infection, according to a British study.